SCLEROSING RHABDOMYOSARCOMA

Clinical trials for SCLEROSING RHABDOMYOSARCOMA explained in plain language.

Never miss a new study

Get alerted when new SCLEROSING RHABDOMYOSARCOMA trials appear

Sign up with your email to follow new studies for SCLEROSING RHABDOMYOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Major trial seeks better treatment for aggressive childhood cancer

Disease control Ongoing

This study is for children and young adults (up to age 40) with intermediate-risk rhabdomyosarcoma, a type of muscle cancer. It compares the current standard chemotherapy to the same chemotherapy plus a newer drug called temsirolimus. The goal is to see if adding temsirolimus hel…

Matched conditions: SCLEROSING RHABDOMYOSARCOMA

Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

SCLEROSING RHABDOMYOSARCOMA

Get alerted when new SCLEROSING RHABDOMYOSARCOMA trials appear

Major trial seeks better treatment for aggressive childhood cancer